Critical role of TNF-α in cerebral aneurysm formation and progression to rupture

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Starke, Robert M ^a,b   Chalouhi, Nohra ^a   Jabbour, Pascal M ^a   Tjoumakaris, Stavropoula I ^a   Gonzalez, L F ^a   Rosenwasser, Robert H ^a   Wada, Kosuke ^c   Shimada, Kenji ^c   Hasan, David M ^d   Greig, Nigel H ^e   Owens, Gary K ^f   Dumont, Aaron S ^a,g  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f UNIVERSITY OF VIRGINIA   (United States)

^g TULANE UNIVERSITY   (United States)

Author keywords

Aneurysm; Cerebral; Rupture; Subarachnoid hemorrhage; TNF alpha; Tumor necrosis factor

Indexed keywords

3,6' DITHIOTHALIDOMIDE; ELASTASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG; 3,6'-DITHIOTHALIDOMIDE; THALIDOMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL CISTERN; BRAIN ARTERY ANEURYSM; BRAIN ARTERY ANEURYSM RUPTURE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HYPERTENSION; IMMUNOFLUORESCENCE TEST; KNOCKOUT MOUSE; MALE; MOUSE; NEUROPATHOLOGY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; SUBARACHNOID HEMORRHAGE; ANALOGS AND DERIVATIVES; ANEURYSM, RUPTURED; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD PRESSURE; BLOOD VESSEL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; INTRACRANIAL ANEURYSM; METABOLISM; PATHOLOGY; PHYSIOLOGY; TIME; TRANSGENIC MOUSE;

ANEURYSM, RUPTURED; ANIMALS; BLOOD PRESSURE; BLOOD VESSELS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; GENE EXPRESSION REGULATION; INTRACRANIAL ANEURYSM; MALE; MICE; MICE, TRANSGENIC; RNA, MESSENGER; THALIDOMIDE; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899471790     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-77     Document Type: Article

References (34)

1. Molyneux AJ, Kerr RS, Birks J, Ramzi N, Yarnold J, Sneade M, Rischmiller J. Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up. Lancet Neurol 2009, 8:427-433. 10.1016/S1474-4422(09)70080-8, 2669592, 19329361.
2. Wiebers DO, Whisnant JP, Huston J, Meissner I, Brown RD, Piepgras DG, Forbes GS, Thielen K, Nichols D, O'Fallon WM, Peacock J, Jaeger L, Kassell NF, Kongable-Beckman GL, Torner JC, International Study of Unruptured Intracranial Aneurysms Investigators Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003, 362:103-110. 10.1016/S0140-6736(03)13860-3, 12867109, International Study of Unruptured Intracranial Aneurysms Investigators.
3. Morita A, Kirino T, Hashi K, Aoki N, Fukuhara S, Hashimoto N, Nakayama T, Sakai M, Teramoto A, Tominari S, Yoshimoto T. The natural course of unruptured cerebral aneurysms in a Japanese cohort. N Engl J Med 2012, 366:2474-2482.
4. Chalouhi N, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Koch WJ, Dumont AS. Biology of intracranial aneurysms: role of inflammation. J Cereb Blood Flow Metab 2012, 32:1659-1676. 10.1038/jcbfm.2012.84, 3434628, 22781330.
5. Jayaraman T, Berenstein V, Li X, Mayer J, Silane M, Shin YS, Niimi Y, Kilic T, Gunel M, Berenstein A. Tumor necrosis factor alpha is a key modulator of inflammation in cerebral aneurysms. Neurosurgery 2005, 57:558-564. discussion 558-564, 10.1227/01.NEU.0000170439.89041.D6, 16145536.
6. Jayaraman T, Paget A, Shin YS, Li X, Mayer J, Chaudhry H, Niimi Y, Silane M, Berenstein A. TNF-alpha-mediated inflammation in cerebral aneurysms: a potential link to growth and rupture. Vasc Health Risk Manag 2008, 4:805-817. 2597764, 19065997.
7. Kleinbongard P, Heusch G, Schulz R. TNF alpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure. Pharmacol Ther 2010, 127:295-314. 10.1016/j.pharmthera.2010.05.002, 20621692.
8. Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Owens GK, Koch WJ, Greig NH, Dumont AS. TNF-alpha induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology. J Cereb Blood Flow Metab 2013, 33:1564-1573. 10.1038/jcbfm.2013.109, 23860374.
9. Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van Rooijen N, Lawton MT, Young WL, Liang EI, Nuki Y, Hashimoto T. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke 2011, 42:173-178. 10.1161/STROKEAHA.110.590976, 3021554, 21106959.
10. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581. 10.1152/physrev.00024.2005, 16601268.
11. Hara A, Yoshimi N, Mori H. Evidence for apoptosis in human intracranial aneurysms. Neurol Res 1998, 20:127-130.
12. National Research Counci Guide for the Care and Use of Laboratory Animals: Eighth Edition 2011, Washington, DC: The National Academies Press, National Research Counci.
13. Nuki Y, Tsou TL, Kurihara C, Kanematsu M, Kanematsu Y, Hashimoto T. Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension 2009, 54:1337-1344. 10.1161/HYPERTENSIONAHA.109.138297, 2797444, 19884566.
14. Makino H, Tada Y, Wada K, Liang EI, Chang M, Mobashery S, Kanematsu Y, Kurihara C, Palova E, Kanematsu M, Kitazato K, Hashimoto T. Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke 2012, 43:2450-2456. 10.1161/STROKEAHA.112.659821, 3429647, 22798328.
15. Weiss D, Taylor WR. Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/-mice results in accelerated atherosclerosis: the role of angiotensin II. Hypertension 2008, 51:218-224. 10.1161/HYPERTENSIONAHA.107.095885, 18158357.
16. Nagata I, Handa H, Hashimoto N, Hazama F. Experimentally induced cerebral aneurysms in rats: part VI. Hypertension. Surg Neurol 1980, 14:477-479.
17. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 1994, 265:1883-1885. 10.1126/science.7522345, 7522345.
18. Jeon H, Ai J, Sabri M, Tariq A, Shang X, Chen G, Macdonald RL. Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage. BMC Neurosci 2009, 10:103. 10.1186/1471-2202-10-103, 2749856, 19706182.
19. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Kamii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 1994, 25:165-170. 10.1161/01.STR.25.1.165, 8266365.
20. Jankowski M, Rachelska G, Donghao W, McCann SM, Gutkowska J. Estrogen receptors activate atrial natriuretic peptide in the rat heart. Proc Natl Acad Sci U S A 2001, 98:11765-11770. 10.1073/pnas.201394198, 58804, 11562484.
21. Luo WM, Yu QS, Tweedie D, Deschamps J, Parrish D, Holloway HW, Li YZ, Brossi A, Greig NH. Synthesis of aromatic substituted 6'-thaiothalidomides. Synthesis 2008, 2008:3415-3422.
22. Belarbi K, Jopson T, Tweedie D, Arellano C, Luo W, Greig NH, Rosi S. TNF-alpha protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation. J Neuroinflammation 2012, 9:23. 10.1186/1742-2094-9-23, 3298520, 22277195.
23. Starke RM, Ali MS, Jabbour PM, Tjoumakaris SI, Gonzalez F, Hasan DM, Rosenwasser RH, Owens GK, Koch WJ, Dumont AS. Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease. PLoS One 2013, 8:e71954. 10.1371/journal.pone.0071954, 3743809, 23967268.
24. Schievink WI. Intracranial aneurysms. N Engl J Med 1997, 336:28-40. 10.1056/NEJM199701023360106, 8970938.
25. Chalouhi N, Ali MS, Starke RM, Jabbour PM, Tjoumakaris SI, Gonzalez LF, Rosenwasser RH, Koch WJ, Dumont AS. Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture. Mediators Inflamm 2013, 2012:271582.
26. Wright JL, Tai H, Wang R, Wang X, Churg A. Cigarette smoke upregulates pulmonary vascular matrix metalloproteinases via TNF-alpha signaling. Am J Physiol Lung Cell Mol Physiol 2007, 292:L125-L133.
27. Fan J, Li X, Zhong L, Hao T, Di J, Liu F, Zhao HH, Bai SL. MCP-1, ICAM-1 and VCAM-1 are present in early aneurysmal dilatation in experimental rats. Folia Histochem Cytobiol 2010, 48:455-461.
28. Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K, Hashimoto N. Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke 2006, 37:900-905. 10.1161/01.STR.0000204028.39783.d9, 16439700.
29. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002, 39:279-291. 10.1002/glia.10108, 12203394.
30. Kim SC, Singh M, Huang J, Prestigiacomo CJ, Winfree CJ, Solomon RA, Connolly ES. Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 1997, 41:642-666. discussion 646-647.
31. Nakajima N, Nagahiro S, Sano T, Satomi J, Satoh K. Phenotypic modulation of smooth muscle cells in human cerebral aneurysmal walls. Acta Neuropathol 2000, 100:475-480. 10.1007/s004010000220, 11045669.
32. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003, 10:45-65. 10.1038/sj.cdd.4401189, 12655295.
33. Aoki T, Kataoka H, Morimoto M, Nozaki K, Hashimoto N. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 2007, 38:162-169. 10.1161/01.STR.0000252129.18605.c8, 17122420.
34. Kondo S, Hashimoto N, Kikuchi H, Hazama F, Nagata I, Kataoka H. Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 1998, 29:181-188. discussion 189, 10.1161/01.STR.29.1.181, 9445349.